{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:49:24Z","timestamp":1783396164906,"version":"3.54.6"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10637-013-9995-y","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T08:07:41Z","timestamp":1375258061000},"page":"75-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Preclinical studies of targeted therapies for CD20-positive B lymphoid malignancies by Ofatumumab conjugated with auristatin"],"prefix":"10.1007","volume":"32","author":[{"given":"Zhao Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Qiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Naranmandura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"issue":"9","key":"9995_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.bcp.2012.08.002","volume":"84","author":"M Sioud","year":"2012","unstructured":"Sioud M, Mobergslien A (2012) Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide. Biochem Pharmacol 84(9):1123\u20131132. doi:10.1016\/j.bcp.2012.08.002","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"9995_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4155\/tde.10.98","volume":"2","author":"VS Goldmacher","year":"2011","unstructured":"Goldmacher VS, Kovtun YV (2011) Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells. Ther Deliv 2(3):397\u2013416","journal-title":"Ther Deliv"},{"issue":"11","key":"9995_CR3","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1007\/s11095-012-0810-9","volume":"29","author":"GD Stack","year":"2012","unstructured":"Stack GD, Walsh JJ (2012) Optimising the delivery of tubulin targeting agents through antibody conjugation. Pharm Res 29(11):2972\u20132984. doi:10.1007\/s11095-012-0810-9","journal-title":"Pharm Res"},{"issue":"9","key":"9995_CR4","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1517\/14712598.2012.693473","volume":"12","author":"JR Adair","year":"2012","unstructured":"Adair JR, Howard PW, Hartley JA, Williams DG, Chester KA (2012) Antibody-drug conjugates - a perfect synergy. Expert Opin Biol Ther 12(9):1191\u20131206. doi:10.1517\/14712598.2012.693473","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"9995_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0167-5699(94)90276-3","volume":"15","author":"TF Tedder","year":"1994","unstructured":"Tedder TF, Engel P (1994) CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today 15(9):450\u2013454. doi:10.1016\/0167-5699(94)90276-3","journal-title":"Immunol Today"},{"issue":"26","key":"9995_CR6","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1200\/JCO.2005.06.004","volume":"23","author":"DG Maloney","year":"2005","unstructured":"Maloney DG (2005) Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines. J Clin Oncol 23(26):6421\u20136428. doi:10.1200\/JCO.2005.06.004","journal-title":"J Clin Oncol"},{"issue":"8","key":"9995_CR7","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16(8):2825\u20132833","journal-title":"J Clin Oncol"},{"issue":"6","key":"9995_CR8","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1182\/blood-2004-01-0039","volume":"104","author":"JL Teeling","year":"2004","unstructured":"Teeling JL, French RR, Cragg MS, van den Brakel J, Pluyter M, Huang H, Chan C, Parren PW, Hack CE, Dechant M, Valerius T, van de Winkel JG, Glennie MJ (2004) Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas. Blood 104(6):1793\u20131800. doi:10.1182\/blood-2004-01-0039","journal-title":"Blood"},{"issue":"21","key":"9995_CR9","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1200\/JCO.2010.27.9836","volume":"28","author":"BD Cheson","year":"2010","unstructured":"Cheson BD (2010) Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies. J Clin Oncol 28(21):3525\u20133530. doi:10.1200\/JCO.2010.27.9836","journal-title":"J Clin Oncol"},{"issue":"4","key":"9995_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4161\/mabs.1.4.8895","volume":"1","author":"B Zhang","year":"2009","unstructured":"Zhang B (2009) Ofatumumab. MAbs 1(4):326\u2013331","journal-title":"MAbs"},{"key":"9995_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/JBM.S13063","volume":"2","author":"M Veliz","year":"2011","unstructured":"Veliz M, Pinilla-Ibarz J (2011) Role of ofatumumab in treatment of chronic lymphocytic leukemia. J Blood Med 2:71\u201377. doi:10.2147\/JBM.S13063","journal-title":"J Blood Med"},{"issue":"4","key":"9995_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/2040620712445329","volume":"3","author":"MJ Dyer","year":"2012","unstructured":"Dyer MJ (2012) Safety and efficacy of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemia. Ther Adv Hematol 3(4):199\u2013207. doi:10.1177\/2040620712445329","journal-title":"Ther Adv Hematol"},{"issue":"5","key":"9995_CR13","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1021\/bc050201y","volume":"16","author":"MM Sun","year":"2005","unstructured":"Sun MM, Beam KS, Cerveny CG, Hamblett KJ, Blackmore RS, Torgov MY, Handley FG, Ihle NC, Senter PD, Alley SC (2005) Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides. Bioconjug Chem 16(5):1282\u20131290. doi:10.1021\/bc050201y","journal-title":"Bioconjug Chem"},{"issue":"4","key":"9995_CR14","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/blood-2003-01-0039","volume":"102","author":"JA Francisco","year":"2003","unstructured":"Francisco JA, Cerveny CG, Meyer DL, Mixan BJ, Klussman K, Chace DF, Rejniak SX, Gordon KA, DeBlanc R, Toki BE, Law CL, Doronina SO, Siegall CB, Senter PD, Wahl AF (2003) cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood 102(4):1458\u20131465. doi:10.1182\/blood-2003-01-0039","journal-title":"Blood"},{"issue":"6","key":"9995_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.bcp.2007.06.044","volume":"74","author":"KY Han","year":"2007","unstructured":"Han KY, Yang D, Chang EJ, Lee Y, Huang H, Sung SH, Lee ZH, Kim YC, Kim HH (2007) Inhibition of osteoclast differentiation and bone resorption by sauchinone. Biochem Pharmacol 74(6):911\u2013923. doi:10.1016\/j.bcp.2007.06.044","journal-title":"Biochem Pharmacol"},{"issue":"23","key":"9995_CR16","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.1158\/1078-0432.CCR-04-1028","volume":"10","author":"CL Law","year":"2004","unstructured":"Law CL, Cerveny CG, Gordon KA, Klussman K, Mixan BJ, Chace DF, Meyer DL, Doronina SO, Siegall CB, Francisco JA, Senter PD, Wahl AF (2004) Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates. Clin Cancer Res 10(23):7842\u20137851. doi:10.1158\/1078-0432.CCR-04-1028","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9995_CR17","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.4049\/jimmunol.180.6.3938","volume":"180","author":"JM Beekman","year":"2008","unstructured":"Beekman JM, van der Poel CE, van der Linden JA, van den Berg DL, van den Berghe PV, van de Winkel JG, Leusen JH (2008) Filamin A stabilizes Fc gamma RI surface expression and prevents its lysosomal routing. J Immunol 180(6):3938\u20133945","journal-title":"J Immunol"},{"issue":"1","key":"9995_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2010.01.023","volume":"294","author":"M Lv","year":"2010","unstructured":"Lv M, Lin Z, Qiao C, Gen S, Lang X, Li Y, Feng J, Shen B (2010) Novel anti-CD20 antibody TGLA with enhanced antibody-dependent cell-mediated cytotoxicity mediates potent anti-lymphoma activity. Cancer Lett 294(1):66\u201373. doi:10.1016\/j.canlet.2010.01.023","journal-title":"Cancer Lett"},{"issue":"1","key":"9995_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/toxsci\/kfs154","volume":"128","author":"H Naranmandura","year":"2012","unstructured":"Naranmandura H, Chen X, Tanaka M, Wang WW, Rehman K, Xu S, Chen Z, Chen SQ, Suzuki N (2012) Release of apoptotic cytochrome C from mitochondria by dimethylarsinous acid occurs through interaction with voltage-dependent anion channel in vitro. Toxicol Sci 128(1):137\u2013146. doi:10.1093\/toxsci\/kfs154","journal-title":"Toxicol Sci"},{"issue":"20","key":"9995_CR20","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1158\/1078-0432.CCR-04-0789","volume":"10","author":"KJ Hamblett","year":"2004","unstructured":"Hamblett KJ, Senter PD, Chace DF, Sun MM, Lenox J, Cerveny CG, Kissler KM, Bernhardt SX, Kopcha AK, Zabinski RF, Meyer DL, Francisco JA (2004) Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin Cancer Res 10(20):7063\u20137070. doi:10.1158\/1078-0432.CCR-04-0789","journal-title":"Clin Cancer Res"},{"key":"9995_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-med-050311-201823","volume":"64","author":"EL Sievers","year":"2013","unstructured":"Sievers EL, Senter PD (2013) Antibody-drug conjugates in cancer therapy. Annu Rev Med 64:15\u201329. doi:10.1146\/annurev-med-050311-201823","journal-title":"Annu Rev Med"},{"issue":"4","key":"9995_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1021\/bc100480a","volume":"22","author":"BA Kellogg","year":"2011","unstructured":"Kellogg BA, Garrett L, Kovtun Y, Lai KC, Leece B, Miller M, Payne G, Steeves R, Whiteman KR, Widdison W, Xie H, Singh R, Chari RV, Lambert JM, Lutz RJ (2011) Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage. Bioconjug Chem 22(4):717\u2013727. doi:10.1021\/bc100480a","journal-title":"Bioconjug Chem"},{"issue":"6","key":"9995_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF01741596","volume":"33","author":"GR Braslawsky","year":"1991","unstructured":"Braslawsky GR, Kadow K, Knipe J, McGoff K, Edson M, Kaneko T, Greenfield RS (1991) Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity. Cancer Immunol Immunother 33(6):367\u2013374","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"9995_CR24","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood.V90.6.2364","volume":"90","author":"AC Goulet","year":"1997","unstructured":"Goulet AC, Goldmacher VS, Lambert JM, Baron C, Roy DC, Kouassi E (1997) Conjugation of blocked ricin to an anti-CD19 monoclonal antibody increases antibody-induced cell calcium mobilization and CD19 internalization. Blood 90(6):2364\u20132375","journal-title":"Blood"},{"issue":"10","key":"9995_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1345\/aph.1P780","volume":"45","author":"G Nightingale","year":"2011","unstructured":"Nightingale G (2011) Ofatumumab: a novel anti-CD20 monoclonal antibody for treatment of refractory chronic lymphocytic leukemia. Ann Pharmacother 45(10):1248\u20131255. doi:10.1345\/aph.1P780","journal-title":"Ann Pharmacother"},{"key":"9995_CR26","first-page":"51","volume":"3","author":"TS Lin","year":"2010","unstructured":"Lin TS (2010) Ofatumumab: a novel monoclonal anti-CD20 antibody. Pharmgenomics Pers Med 3:51\u201359","journal-title":"Pharmgenomics Pers Med"},{"issue":"8","key":"9995_CR27","first-page":"2701","volume":"8","author":"RB Michel","year":"2002","unstructured":"Michel RB, Mattes MJ (2002) Intracellular accumulation of the anti-CD20 antibody 1F5 in B-lymphoma cells. Clin Cancer Res 8(8):2701\u20132713","journal-title":"Clin Cancer Res"},{"key":"9995_CR28","first-page":"1","volume":"70","author":"GR Pettit","year":"1997","unstructured":"Pettit GR (1997) The dolastatins. Fortschr Chem Org Naturst 70:1\u201379","journal-title":"Fortschr Chem Org Naturst"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9995-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-013-9995-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9995-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9995-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:44:37Z","timestamp":1678509877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-013-9995-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9995"],"URL":"https:\/\/doi.org\/10.1007\/s10637-013-9995-y","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]},"assertion":[{"value":"5 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}